Showing 1 - 3 results of 3 for search 'Xinxin Cao', query time: 0.01s
Refine Results
-
1
-
2
-
3
Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned surv... by Gang Fang, Zhipeng Pi, Yiping An, Xinxin Cao, Wei Li, Wei Li, Xiangjun Zhu, Jinxi Ding, Jinxi Ding
Published 2025-01-01
Article